| Characteristics | HFRT group (n = 50) | CFRT group (n = 50) | P value |
| Age (years) |
|
|
|
| Median | 47 | 50 | 0.9 |
| Range | 31 - 64 | 34 - 68 | |
| Laterality side |
|
|
|
| Left | 31 (62%) | 29 (58%) | 0.7 |
| Right | 19 (38%) | 21 (42%) | |
| stage |
|
|
|
| IIa | 6 (12%) | 8 (16%) | 0.8 |
| IIb | 13 (26%) | 16 (32%) | |
| IIIa | 27 (54%) | 21 (42%) | |
| IIIb | 2 (4%) | 3 (6%) | |
| IIIc | 2 (4%) | 2 (4%) | |
| Grade |
|
|
|
| II | 39 (78%) | 41 (82%) | 0.6 |
| III | 11 (22%) | 9 (18%) | |
| Histological type |
|
|
|
| IDC | 50 (100%) | 50 (100%) |
|
| Hormonal status: |
|
|
|
| ER: |
|
|
|
| +ve | 39 (78%) | 36 (72%) | 0.5
0.6
0.06 |
| −ve | 11 (22%) | 14 (28%) | |
| PR: |
|
| |
| +ve | 34 (68%) | 31 (62%) | |
| −ve | 16 (32%) | 19 (38%) | |
| HER-2: |
|
| |
| +ve | 21 (42%) | 15 (30%) | |
| −ve | 24 (48%) | 21 (42%) | |
| Not determined | 5 (10%) | 14 (28%) | |
| Menopausal status: |
|
|
|
| Premenopausal | 25 (50%) | 21 (42%) | 0.7 |
| perimenopausal | 6 (12%) | 7 (14%) | |
| postmenopausal | 19 (38%) | 22 (44%) |